Evidence map›Paper›PMID 31832559›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2019

Antiprogramed cell death-1 therapy with microspheres for metastatic liver tumors.

Hiroteru Kamimura, Nobutaka Takeda, Takashi Owaki, Takeshi Mizusawa, Takahiro Iwasawa, Satoshi Ikarashi, Satoru Hashimoto, Masaaki Takamura, Shuji Terai

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroteru KamimuraDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.ORCID https://orcid.org/0000-0002-9135-3092
Nobutaka TakedaDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.
Takashi OwakiDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.
Takeshi MizusawaDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.
Takahiro IwasawaDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.
Satoshi IkarashiDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.
Satoru HashimotoDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.
Masaaki TakamuraDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.
Shuji TeraiDivision of Gastroenterology and Hepatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-programmed cell death-1 therapy with microspheres is an effective treatment for metastatic liver tumors.

Indexed as

anti‐programmed cell death‐1 therapymelanomametastatic liver tumor

Identifiers

PMID31832559
PMCPMC6891027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.